Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lumecare Hypromellose (also known as Lumecare® Hypromellose or Hypromellose 0.3% w/v) is a preservative-free topical ophthalmic solution developed and manufactured by Medicom Healthcare. Its active ingredient is hypromellose (hydroxypropyl methylcellulose) at a concentration of 0.3% w/v, which acts as an ocular lubricant and artificial tear substitute. It is indicated for the symptomatic relief of dry eye disease, providing hydration and protecting the ocular surface from irritation and discomfort caused by environmental factors, prolonged screen use, or contact lens wear. The formulation is sterile and available in both multi-dose bottles and single-use vials.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lumecare Hypromellose.